Product Highlight - XOFLUZA
ONE AND DONE
- Taken only once, Xofluza stops viral replication leading to undetectable levels of virus* within 24 hours** and provides patients with flu relief within 2-3 days^,1,2
- Xofluza the first-in-class influenza antiviral in 20 years with a novel mode of action3
* Infectious virus
**In otherwise healthy patients with influenza in the CAPSTONE-1 study, Xofluza demonstrated a median time to cessation of viral shedding of 24 hours vs. 96 hours with placebo and 72 hours with oseltamivir (p<0.001 vs. both placebo and oseltamivir)
^Median time to alleviation of symptoms was 54 hours (2.3 days) with Xofluza compared with 80 hours (3.3 days) with placebo (p<0.001), in otherwise healthy patients with influenza in the CAPSTONE-1 study.
1. Hayden FG et al. N Engl J Med 2018; 379: 913–923.
2. Xofluza Prescribing Information, Malaysia. MYXofluza20200520CDS7.1
3. Noshi T el al. Antiviral Res 2018; 160: 109-117.